CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany.

MLA

Kranz, Lena M., et al. “CIMT 2016: Mechanisms of Efficacy in Cancer Immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany.” Human Vaccines & Immunotherapeutics, vol. 12, no. 11, Nov. 2016, pp. 2805–12. EBSCOhost, https://doi.org/10.1080/21645515.2016.1206677.

APA

Kranz, L. M., Birtel, M., Hilscher, L., Grunwitz, C., Petschenka, J., Vascotto, F., Vormehr, M., Voss, R.-H., Kreiter, S., & Diken, M. (2016). CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany. Human Vaccines & Immunotherapeutics, 12(11), 2805–2812. https://doi.org/10.1080/21645515.2016.1206677

Chicago

Kranz, Lena M., Matthias Birtel, Lina Hilscher, Christian Grunwitz, Jutta Petschenka, Fulvia Vascotto, Mathias Vormehr, Ralf-Holger Voss, Sebastian Kreiter, and Mustafa Diken. 2016. “CIMT 2016: Mechanisms of Efficacy in Cancer Immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany.” Human Vaccines & Immunotherapeutics 12 (11): 2805–12. doi:10.1080/21645515.2016.1206677.